<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <title>DSpace Общество:</title>
  <link rel="alternate" href="http://ir.librarynmu.com/handle/123456789/39" />
  <subtitle />
  <id>http://ir.librarynmu.com/handle/123456789/39</id>
  <updated>2026-06-24T20:44:27Z</updated>
  <dc:date>2026-06-24T20:44:27Z</dc:date>
  <entry>
    <title>Bacteriological and biochemical features of peritonitis in perforative pyloroduodenal ulcer</title>
    <link rel="alternate" href="http://ir.librarynmu.com/handle/123456789/19844" />
    <author>
      <name>Kolosovych, I.</name>
    </author>
    <author>
      <name>Hanol, I.</name>
    </author>
    <id>http://ir.librarynmu.com/handle/123456789/19844</id>
    <updated>2026-06-23T12:23:59Z</updated>
    <published>2026-01-01T00:00:00Z</published>
    <summary type="text">Название: Bacteriological and biochemical features of peritonitis in perforative pyloroduodenal ulcer
Авторы: Kolosovych, I.; Hanol, I.
Краткий осмотр (реферат): Despite a wide range of available surgical interventions, the optimal strategy for perforated pyloroduodenal&#xD;
ulcers, including cases combined with other complications, remains undetermined. The use of conventional&#xD;
techniques in patients with peritonitis is often associated with purulent-septic complications. The aim of the&#xD;
work was to investigate the pathophysiological features of peritonitis in perforated pyloroduodenal ulcer&#xD;
and their influence on the course of this disease. The study included 158 patients aged 20-73 years, divided&#xD;
into three groups according to the duration of peritonitis: up to 6 h (n = 99), 6-12 h (n = 35), and more&#xD;
than 12 h (n = 24). All patients underwent bacteriological examination, measurement of abdominal exudate&#xD;
pH at different stages of peritonitis, and analysis of clinical and laboratory parameters. The duration of&#xD;
peritonitis was found to be associated with a higher degree of bacterial contamination of the abdominal&#xD;
cavity. Within 60 minutes after perforation, the initially acidic gastric contents in the abdominal cavity&#xD;
become neutralized; at an exudate pH of 7, optimal conditions for pathogenic microflora are established.&#xD;
Thus, the presented clinical, laboratory and bacteriological results indicate that during the first 3-5 days&#xD;
of the early postoperative period, the patient’s body continues to fight the consequences of post-perforation&#xD;
peritonitis.</summary>
    <dc:date>2026-01-01T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>Topical Application of Autologous Plasma-Derived Plasminogen Accelerates Healing of Chronic Foot Ulcers in Type 2 Diabetes Patients</title>
    <link rel="alternate" href="http://ir.librarynmu.com/handle/123456789/13753" />
    <author>
      <name>Petrenko, O.</name>
    </author>
    <author>
      <name>Badziukh, S.</name>
    </author>
    <author>
      <name>Korsa, V.</name>
    </author>
    <author>
      <name>Kolosovych, I.</name>
    </author>
    <author>
      <name>Tykhomyrov, A.</name>
    </author>
    <id>http://ir.librarynmu.com/handle/123456789/13753</id>
    <updated>2026-06-04T11:41:16Z</updated>
    <published>2026-01-01T00:00:00Z</published>
    <summary type="text">Название: Topical Application of Autologous Plasma-Derived Plasminogen Accelerates Healing of Chronic Foot Ulcers in Type 2 Diabetes Patients
Авторы: Petrenko, O.; Badziukh, S.; Korsa, V.; Kolosovych, I.; Tykhomyrov, A.
Краткий осмотр (реферат): Plasminogen (Pg) is currently considered a master regulator of wound healing, but the molecular mechanisms of its efficacy in improving impaired closure of chronic skin ulcers in type 2 diabetes patients remain unclear. Here, we investigated&#xD;
wound healing effects of autologous plasma-derived Pg in diabetes patients with chronic foot ulcers and evaluated Pginduced changes in levels of key protein markers related to wound repair. Type 2 diabetes patients with chronic wounds&#xD;
of lower extremities were included in the study and received topical applications of Pg in a dose of 1.0 mg/mL every 2 days&#xD;
during 20 days, in addition to the standard wound management treatment. Patients treated only according to conventional&#xD;
protocol served as a control. Wound closure rates were monitored by digital planimetry of wound areas. Plasminogen supplementary treatment significantly accelerated relative wound closure as compared with diabetes patients from the control&#xD;
group (24 ± 4 days vs 120 ± 17 days, respectively, P &lt; .01). As shown by Western blot, Pg application reduced expression of&#xD;
protein regulators of hypoxia events, angiogenesis, and autophagy such as hypoxia-inducible factor-1α (by 6.3-folds, P &lt; .01),&#xD;
angiostatins (by 2.5-folds, P &lt; .05), and autophagy marker LC3-II/LC3-I (by 8.6-folds, P &lt; .05), while increasing vascular endothelial growth factor level by 1.9-folds (P &lt; .05). Gelatin zymography showed that Pg-supplemented therapy decreased activity of matrix metalloproteinase-9 (MMP-9) by 3.5-folds at the end of treatment period (P &lt; .01). We report here for the&#xD;
first time that topically applied plasma-derived Pg has a pronounced beneficial effect in promoting foot ulcer healing in&#xD;
patients with type 2 diabetes through preventing hypoxia-induced signaling, reducing autophagy flux, diminishing excessive MMP activity, and enhancing angiogenesis.</summary>
    <dc:date>2026-01-01T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>The state of neutrophilic granulocyte indices in patients with acute infected necrotizing pancreatitis depending on the type of pathogen</title>
    <link rel="alternate" href="http://ir.librarynmu.com/handle/123456789/19713" />
    <author>
      <name>Stasenko, A.</name>
    </author>
    <author>
      <name>Dibrova, Y.</name>
    </author>
    <id>http://ir.librarynmu.com/handle/123456789/19713</id>
    <updated>2026-06-03T07:55:53Z</updated>
    <published>2026-01-01T00:00:00Z</published>
    <summary type="text">Название: The state of neutrophilic granulocyte indices in patients with acute infected necrotizing pancreatitis depending on the type of pathogen
Авторы: Stasenko, A.; Dibrova, Y.
Краткий осмотр (реферат): Th e aim of the work was to study the state of polymorphonuclear leukocytes (PMN)  in patients with acute infected necrotizing pancreatitis (AINP) depending on the type of pathogen.</summary>
    <dc:date>2026-01-01T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>Splenic hyperkinetic syndrome: a universal driver of cirrhotic and non-cirrhotic portal hypertension</title>
    <link rel="alternate" href="http://ir.librarynmu.com/handle/123456789/19712" />
    <author>
      <name>Kozlov, S.</name>
    </author>
    <author>
      <name>Kolosovych, I.</name>
    </author>
    <author>
      <name>Yakovenko, N.</name>
    </author>
    <id>http://ir.librarynmu.com/handle/123456789/19712</id>
    <updated>2026-06-03T07:47:09Z</updated>
    <published>2026-01-01T00:00:00Z</published>
    <summary type="text">Название: Splenic hyperkinetic syndrome: a universal driver of cirrhotic and non-cirrhotic portal hypertension
Авторы: Kozlov, S.; Kolosovych, I.; Yakovenko, N.
Краткий осмотр (реферат): Portal hypertension (PH) is attributed to increased intrahepatic resistance. However, the role of splanchnic&#xD;
hyperdynamic circulation, specifically excessive inflow, remains underappreciated.We hypothesized that splenic arterial hyperperfusion acts as a universal hemodynamic driver in PH - regardless of etiology - creating a volume overload that the portal system cannot accommodate. This study aims to evaluate the relations between splenic arterial inflow and portal venous flow in patients with established cirrhotic and non-cirrhotic PH.</summary>
    <dc:date>2026-01-01T00:00:00Z</dc:date>
  </entry>
</feed>

